Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. The company offers Retrocyte Display, a platform that screens and generates therapeutic antibody drug candidates focused on advancing checkpoint modulators using a high-throughput approach incorporating human antibody libraries expressed in mammalian B-lymphocytes. It is also developing heat shock protein vaccine, which is in Phase II studies for treating cancer and infectious diseases; and QS-21 Stimulon, a saponin-based vaccine adjuvant for use in pre-clinical and clinical stage vaccine programs that target prophylactic or therapeutic impact in a range of infectious diseases and cancer.
Want amazing results? Subscribe for tips on success!
Did You Know?
JP Morgan's trading guru says stock rebound to continue, yield decline not based on fundamentals
on August 20, 2019 at 12:04 pm
For investors still haunted by last week's monster sell-off, the market's comeback is set to last, according to J.P. Morgan's quant guru.
Stocks making the biggest moves premarket: Home Depot, Kohl's, Medtronic, US Steel & more
on August 20, 2019 at 11:55 am
Names on the move ahead of the open.
5 things to know before the stock market opens Tuesday
on August 20, 2019 at 11:47 am
Dow set to drop; White House denies payroll tax cut report; China tweaks interest rates; Home Depot worries about trade war; Beyond Meat gets an upgrad
Kohl's second-quarter profits beat expectations, but sales miss the mark
on August 20, 2019 at 11:04 am
Kohl's said Tuesday that a strong start to the back-to-school season and new partnership with Amazon helped the retailer beat Wall Street earnings expectations during the second quarter.
Jaguar Land Rover is working on 3D tech that will alert drivers to road hazards
on August 20, 2019 at 10:59 am
As technology develops, manufacturers are working on a number of systems to improve safety.
Home Depot misses on sales, cuts outlook on worries tariffs could hit consumer spending
on August 20, 2019 at 9:23 am
Home Depot's CEO says the retailer cut its outlook partly due to "the potential impacts to the U.S. consumer arising from recently announced tariffs."
Cramer Remix: The amusement park stock that'll bring income to your portfolio
on August 20, 2019 at 12:15 am
Jim Cramer breaks down why investors should invest in Cedar Fairs over Six Flags.
Apple is spending $6 billion on original shows and trying to beat Disney+ to market, reports FT
on August 19, 2019 at 11:00 pm
Apple has spent more than $6 billion on original TV shows and movies for its forthcoming Apple TV+ service, according to a Financial Times report on Monday.
A generational shift in consumer tastes is a boon for these retailers, Jim Cramer says
on August 19, 2019 at 11:00 pm
"These days, the consumer is addicted to convenience ... If it doesn't have a great digital presence or incredible bargains, take a pass," Jim Cramer says.
Cramer's lightning round: The reason investors should own Microsoft
on August 19, 2019 at 10:57 pm
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
active 3 days, 5 hours ago
active 3 days, 8 hours ago
active 3 weeks, 5 days ago
active 2 months ago
active 3 months ago